for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

日本電気株式会社

6701.T

現在値

4,870.00JPY

変化

-65.00(-1.32%)

出来高

571,400

本日のレンジ

4,845.00

 - 

4,925.00

52週レンジ

4,330.00

 - 

5,590.00

∙ 約20分前の相場を表示しています。

適時開示

NEC Corp bought back 2.33 million own shares worth 11.2 billion yen in October

Nov 11 (Reuters) - NEC Corp <6701.T>::: BOUGHT BACK 2.33 MILLION OWN SHARES WORTH 11.2 BILLION YEN IN OCTOBER.

NEC Corp - Bought Back 1,505,800 Own Shares Worth 7.5 Billion Yen In September

Oct 12 (Reuters) - NEC Corp <6701.T>::BOUGHT BACK 1,505,800 OWN SHARES WORTH 7.5 BILLION YEN IN SEPTEMBER.

NEC Corp - Bought Back 280,300 Own Shares Between Aug 30 And Aug 31

Sept 7 - NEC CORP - BOUGHT BACK 280,300 OWN SHARES BETWEEN AUG 30 AND AUG 31:Further company coverage: [].

Nec Says It Will Buy Back Up To 2.46% Of Own Shares Worth 30 Billion Yen

Aug 29 (Reuters) - NEC Corp <6701.T>::NEC SAYS IT WILL BUY BACK UP TO 2.46% OF OWN SHARES WORTH 30 BILLION YEN.

Transgene, NEC Announce Positive Preliminary Data From TG4050 Studies

Nov 22 (Reuters) - TRANSGENE SA <TRNG.PA>::TRANSGENE AND NEC ANNOUNCE POSITIVE PRELIMINARY DATA FROM PHASE I STUDIES OF TG4050, A NOVEL INDIVIDUALIZED NEOANTIGEN CANCER VACCINE.TG4050 WAS WELL TOLERATED, WITH NO RELATED SERIOUS ADVERSE EVENTS REPORTED ACROSS TWO STUDIES TO DATE.TG4050 INDUCED ROBUST ANTI-TUMOR CELLULAR IMMUNE RESPONSES AGAINST MULTIPLE NEOANTIGEN TARGETS IN ALL EVALUABLE PATIENTS (4/4).TG4050 MONOTHERAPY WAS ALSO ASSOCIATED WITH FIRST SIGNS OF CLINICAL ACTIVITY.TG4050 WAS WELL TOLERATED, WITH NO RELATED SERIOUS ADVERSE EVENTS REPORTED ACROSS TWO STUDIES TO DATE..ADDITIONAL PATIENTS ARE BEING ENROLLED, WITH AIM TO TREAT UP TO 43 PATIENTS ACROSS TWO MULTICENTER TRIALS (USA, UK, FRANCE).FURTHER DATA WILL BE RELEASED AT A MAJOR ONCOLOGY CONFERENCE OVER COMING MONTHS AND WILL PROVIDE INSIGHT NEEDED TO PREPARE PHASE II TRIALS.

NEC Corp's Long Position In Hua Hong Semiconductor Falls To 0% - HKEX Filing

Feb 19 (Reuters) - Hong Kong stock exchange filing::NEC CORPORATION'S LONG POSITION IN HUA HONG SEMICONDUCTOR <<<1347.HK>>> DECREASED TO 0% ON FEB 19 FROM 7.62% - HKEX FILING.

Nec To Promote CFO Takayuki Morita To CEO Position -Nikkei

Nov 30 (Reuters) - NEC Corp <6701.T>::NEC TO PROMOTE CFO TAKAYUKI MORITA TO CEO POSITION -NIKKEI.Further company coverage: 6701.T.

Analog Devices Inc Says Co, Nec Corporation Teamed Up To Design 5G Network Mimo Antenna Radio Unit For Rakuten Mobile

Oct 22 (Reuters) - NEC Corp <6701.T>::ANALOG DEVICES INC - CO, NEC CORPORATION TEAMED UP TO DESIGN A 5G NETWORK MIMO ANTENNA RADIO UNIT FOR RAKUTEN MOBILE.

Transgene, NEC And BostonGene Announce Strategic Collaboration For Two Ongoing Clinical Trials

Oct 6 (Reuters) - TRANSGENE SA <TRNG.PA>::TRANSGENE, NEC AND BOSTONGENE ANNOUNCE STRATEGIC COLLABORATION FOR TWO ONGOING CLINICAL TRIALS FOR PATIENTS WITH OVARIAN AND HEAD & NECK CANCERS.COLLABORATION FOR TWO ONGOING PHASE 1 CLINICAL TRIALS OF TG405.

NEC CORP: NTT TO INVEST 64 BILLION YEN IN CO

June 25 (Reuters) - NEC Corp <6701.T>::NEC CORP: NTT TO INVEST 64 BILLION YEN IN CO.NEC CORP: NTT TO TAKE 5% STAKE IN IT.NEC: PAYMENT TO BE MADE ON JULY 10.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up